Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium (myfortic®) in a patient with graft-versus-host disease

被引：0
作者：
Kuhnowski F. [1 ]
Terriou L. [1 ]
Magro L. [1 ]
Jouet J.-P. [1 ]
Yakoub-Agha I. [1 ]
机构：
[1] Service des Maladies du Sang, UAM Allogreffes de CSH, CHRU, Lille
来源：
Drugs | 2006年 / 66卷 / Suppl 2期
关键词：
Imatinib; Tacrolimus; Chronic Myeloid Leukaemia; Mycophenolate Mofetil; Busulfan;
D O I：
10.2165/00003495-200666002-00009
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：29 / 31
页数：2
相关论文
共 50 条
  • [31] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    B Mookerjee
    V Altomonte
    G Vogelsang
    [J]. Bone Marrow Transplantation, 1999, 24 : 517 - 520
  • [32] Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus
    Mookerjee, B
    Altomonte, V
    Vogelsang, G
    [J]. BONE MARROW TRANSPLANTATION, 1999, 24 (05) : 517 - 520
  • [33] Enteric-coated mycophenolate sodium for transplant immunosuppression
    Ingle, GR
    Shah, T
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (21) : 2252 - 2259
  • [34] Review of the immunosuppressant enteric-coated mycophenolate sodium
    Budde, K
    Glander, P
    Diekmann, F
    Waiser, J
    Fritsche, L
    Dragun, D
    Neumayer, HH
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (06) : 1333 - 1345
  • [35] Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients
    Bolin, Paul
    Tanriover, Bekir
    Zibari, Gazi B.
    Lynn, Melissa L.
    Pirsch, John D.
    Chan, Laurence
    Cooper, Matthew
    Langone, Anthony J.
    Tomlanovich, Stephen J.
    [J]. TRANSPLANTATION, 2007, 84 (11) : 1443 - 1451
  • [36] Randomized Trial of Mycophenolate Mofetil Versus Enteric-Coated Mycophenolate Sodium in Primary Renal Transplantation With Tacrolimus and Steroid Avoidance: Four-Year Analysis
    Ciancio, Gaetano
    Gaynor, Jeffrey J.
    Zarak, Alberto
    Sageshima, Junichiro
    Guerra, Giselle
    Roth, David
    Brown, Randolph
    Kupin, Warren
    Chen, Linda
    Tueros, Lissett
    Hanson, Lois
    Ruiz, Phillip
    Burke, George W., III
    [J]. TRANSPLANTATION, 2011, 91 (11) : 1198 - 1205
  • [37] Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium with the Concomitant Use of Proton Pump Inhibitors in Patients who Received Kidney Transplant
    Selcuk, Aysu
    Pehlivanli, Aysel
    Eyupoglu, Sahin
    Ozcelikay, A. Tanju
    Sengul, Sule
    [J]. TURKISH JOURNAL OF NEPHROLOGY, 2022, 31 (04): : 348 - 354
  • [38] Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor-Free Renal Transplant Recipients
    Graff, Jochen
    Scheuermann, Ernst-Heinrich
    Brandhorst, Gunnar
    Oellerich, Michael
    Gossmann, Jan
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 388 - 392
  • [39] Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation
    Langone, Anthony
    Shihab, Fuad
    Pankewycz, Oleh
    Doria, Cataldo
    Wiland, Anne
    McCague, Kevin
    Chan, Laurence
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (09) : 961 - 967
  • [40] Gastrointestinal side effects in liver transplant recipients taking enteric-coated mycophenolate sodium vs. mycophenolate mofetil
    Lopez-Solis, Roberto
    DeVera, Michael
    Steel, Jennifer
    Fedorek, Sheila
    Sturdevant, Mark
    Hughes, Christopher
    Humar, Abhinav
    [J]. CLINICAL TRANSPLANTATION, 2014, 28 (07) : 783 - 788
12345